Sunday - December 28, 2025
FDA Issues Warning Letter to Medinatura New Mexico
December 23, 2025
WASHINGTON, Dec. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Medinatura New Mexico Inc. from the Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Clifford Clive, CEO, Medinatura New Mexico, Inc., 10421 Research Road SE, Albuquerque, NM 87123, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Warning Letter 320-26 . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products